Ansun Biopharma, Inc.

ACTIVE

10045 Mesa Rim Rd, 加利福尼亚州圣迭戈县, California, United Stateswww.ansunbiopharma.comHolding11–50 employeesEstablished: 2003-01-01

Also known as:

ansun

Clinical Trials

4 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2003

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

50.0%

Phase 2

42.9%

Phase 3

7.1%

Trial Status Distribution

Active, not recruiting

28.6%

Completed

50.0%

Recruiting

7.1%

Unknown

7.1%

Withdrawn

7.1%

Clinical Trials

Trials sponsored by this organization (14)

DAS181 for STOP COVID-19

DAS181 for Patients With Severe Hospitalized Flu and SAD-RVs (COVID-19)

Phase 2

Unknown

interventional

Jul 2020280 participants

STOP PIV - Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects

Phase 1

Active, not recruiting

Mar 2020132 participants

STOP PIV - Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects

Phase 1

Active, not recruiting

Nov 2019132 participants

STOP PIV - Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects

Phase 1

Active, not recruiting

Nov 2019192 participants

STOP PIV - Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects

Phase 1

Active, not recruiting

Nov 2019132 participants

Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

Phase 3

Recruiting

interventional

May 2019274 participants

A Phase II, Randomized, Double-blind, Placebo-controlled Study to Examine the Effects of DAS181 in Immunocompromised Subjects With Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen

Phase 2

Completed

interventional

Mar 2014111 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

Back to Organizations